Skip to main content
Main navigation
Loading…

Seòmar agus comataidhean

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

  • Written questions must be answered within 10 working days (20 working days during recess)
  • Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search.  There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Criathragan Hide all filters

Dates of parliamentary sessions
  1. Session 1: 12 May 1999 to 31 March 2003
  2. Session 2: 7 May 2003 to 2 April 2007
  3. Session 3: 9 May 2007 to 22 March 2011
  4. Session 4: 11 May 2011 to 23 March 2016
  5. Session 5: 12 May 2016 to 4 May 2021
  6. Current session: 13 May 2021 to 15 October 2025
Answer status
Question type
Ath-shuidhich an lorg

Displaying 4011 questions Show Answers

|

Question reference: S5W-10625

  • Asked by: Miles Briggs, MSP for Lothian, Scottish Conservative and Unionist Party
  • Date lodged: Wednesday, 09 August 2017
  • Current Status: Answered by Aileen Campbell on 24 August 2017

To ask the Scottish Government what percentage of babies have been fully immunised in each year since 1999.

Question reference: S5W-09135

  • Asked by: Miles Briggs, MSP for Lothian, Scottish Conservative and Unionist Party
  • Date lodged: Wednesday, 03 May 2017
  • Current Status: Answered by Shona Robison on 4 August 2017

To ask the Scottish Government which hospitals have (a) temporarily and (b) fully closed in each year since 2007.

Question reference: S5W-10202

  • Asked by: Miles Briggs, MSP for Lothian, Scottish Conservative and Unionist Party
  • Date lodged: Thursday, 06 July 2017
  • Current Status: Answered by Shona Robison on 2 August 2017

To ask the Scottish Government when the multi-agency taskforce or equivalent group to help introduce new medicines, such as Orkambi for cystic fibrosis, will be established.

Question reference: S5W-10282

  • Asked by: Miles Briggs, MSP for Lothian, Scottish Conservative and Unionist Party
  • Date lodged: Tuesday, 11 July 2017
  • Current Status: Answered by Aileen Campbell on 31 July 2017

To ask the Scottish Government what information it has on how many people with type 1 diabetes have bought their own continuous glucose monitoring (CGM) devices because they cannot access NHS funding for them.

Question reference: S5W-10195

  • Asked by: Miles Briggs, MSP for Lothian, Scottish Conservative and Unionist Party
  • Date lodged: Thursday, 06 July 2017
  • Current Status: Answered by Shona Robison on 28 July 2017

To ask the Scottish Government whether it has made any assessment of the pipeline deal agreed between Vertex Pharmaceuticals and the Irish Government to ensure that people living with cystic fibrosis in Ireland have access to the best treatments for the next 10 years, and what the implications are for negotiations for access to the cystic fibrosis drug, Orkambi, in Scotland and the rest of UK.

Question reference: S5W-10200

  • Asked by: Miles Briggs, MSP for Lothian, Scottish Conservative and Unionist Party
  • Date lodged: Thursday, 06 July 2017
  • Current Status: Answered by Shona Robison on 28 July 2017

To ask the Scottish Government at what stage the review is of the definitions for end-of-life, orphan and ultra-orphan medicines to ensure that the definitions used remain suitable to deal with the assessment of anticipated new treatments such as targeted medicines, such as Orkambi.

Question reference: S5W-10199

  • Asked by: Miles Briggs, MSP for Lothian, Scottish Conservative and Unionist Party
  • Date lodged: Thursday, 06 July 2017
  • Current Status: Answered by Shona Robison on 28 July 2017

To ask the Scottish Government what assessment it has made of the Cystic Fibrosis Trust's proposal for a managed access scheme for the cystic fibrosis drug, Orkambi, using the UK Cystic Fibrosis Patient Registry.

Question reference: S5W-10201

  • Asked by: Miles Briggs, MSP for Lothian, Scottish Conservative and Unionist Party
  • Date lodged: Thursday, 06 July 2017
  • Current Status: Answered by Shona Robison on 28 July 2017

To ask the Scottish Government whether it will clarify the future arrangements for the funding of end-of-life, orphan and ultra-orphan medicines, and what the implications are for the funding of cystic fibrosis drugs.

Question reference: S5W-10197

  • Asked by: Miles Briggs, MSP for Lothian, Scottish Conservative and Unionist Party
  • Date lodged: Thursday, 06 July 2017
  • Current Status: Answered by Shona Robison on 28 July 2017

To ask the Scottish Government what steps it has taken to ensure flexibility in the negotiations between Vertex Pharmaceuticals and NHS Scotland for the reimbursement of the costs of the cystic fibrosis drug, Orkambi.

Question reference: S5W-10196

  • Asked by: Miles Briggs, MSP for Lothian, Scottish Conservative and Unionist Party
  • Date lodged: Thursday, 06 July 2017
  • Current Status: Answered by Shona Robison on 28 July 2017

To ask the Scottish Government what steps it has taken to ensure that the 300 people living with cystic fibrosis in Scotland that are eligible for the drug, Orkambi, have access to the treatment as soon as possible.